In summary, there is a pressing need for large-scale, prospective studies to determine the optimal timing for perioperative cessation of GLP-1RAs, GIP/ GLP-1RAs, and looking ahead emerging triplehormone receptor agonists [44]
Evidence also supports a broader role for CCK-B receptors in modulating feeding behaviors, particularly in stress- or anxiety-related contexts
Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulationa review
doi: 10.1159/000345030
That changed in 2023, when the FDA determined that 19 peptides posed significant safety risks and moved them to a de facto do not compound list
Large cardiovascular outcome trials have demonstrated that several agents in this class reduce major adverse cardiovascular events (MACE) in patients with type 2 diabetes, with benefits extending beyond just those with established cardiovascular disease in some trials